Media-OutReach Newswire CK Life Sciences Files Patent Applications for Circular mRNA TROP2 Cancer Vaccine
Media-OutReach Newswire Li Ka Shing Foundation and Temasek Trust Jointly Commit S$12 Million to Acquire Systems and Advance Clinical Trial for Innovative Histotripsy Cancer Therapy in Singapore
Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Media-OutReach Newswire CGTN: From GDP growth to tech, foreign investment boost, China brings confidence to the world in 2025